Posts Tagged ‘Julià Panés’

Friday July 29th, 2016

Stem cell therapy is effective for the treatment of fistulas in Crohn’s disease

A fat-derived stem cell therapy is effective for the treatment of fistulas in Crohn’s disease. A study published today in The Lancet, has shown that the treatment cures this lesions in 50% of patients, even in cases in which all therapeutic alternatives available fail. Thus, patients can avoid surgery. Dr. Julià Panés, Head of the Gastroenterology Department at Hospital Clínic and of the Inflammatory Bowel Disease IDIBAPS research team, is the principal investigator of the study, in which 49 hospitals in Europe and Israel collaborated. Dr. Damián García-Olmo, head of the Department of Surgery at the Hospital Fundación Jiménez Díaz-Quirónsalud Group, has established the surgical protocol for this study. This is the first Phase III study in the world to test cell therapy for fistulas in Crohn’s disease.

Read the rest of this entry »

Comments Closed
Monday July 27th, 2015

Begins a clinical trial of a new technique to treat Multiple Sclerosis and Neuromyelitis Optica

The Spanish Agency for Medicines and Health Products (AEMPS) has approved a clinical trial in humans with an Antigen-Specific therapy with dendritic cells, a pioneering technique for the treatment of Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO) in a more effective way and with fewer side effects. Dr. Pablo Villoslada, head of the IDIBAPS group Pathogenesis and new treatments in multiple sclerosis, and Dr. Daniel Benitez, researcher at the Inflammatory bowel disease IDIBAPS team, coordinate this trial led by the Hospital Clinic and driven by the Multiple Sclerosis Affected Group Foundation (GAEM) and “la Caixa” Foundation.

Read the rest of this entry »

Comments Closed
Friday February 20th, 2009

Stem Cells to Treat Crohn’s Disease

When drugs don’t work and surgery is not possible, transplanting stem cells from the patient’s own bone marrow is an effective alternative for the treatment of this chronic disease.

Equip mèdic de l'Hospital Clínic amb els tres pacients intervinguts

Cellular therapy with stem cells is revolutionizing the focus of treatment of many serious diseases. Replacing the cells of damaged tissue with other new cells from the same patient is already a reality. This is the basis of cellular therapy and regenerative medicine, the latest great advance in biomedicine. In this line, Hospital Clínic, Barcelona is leading the world in the application of an innovative cellular therapy that uses stem cells to treat Crohn’s disease, a chronic genetic disease that affects 1% of the population in Spain and which has considerable impact on the quality of life of the patients. The procedure is based on an autologous bone-marrow transplant (when patients receive a transplant of their own stem cells) and now constitutes a treatment option to cure an intestinal disease that sometimes does not successfully respond to drugs and requires highly complex surgery that does not provide a cure.

Read the rest of this entry »

Comments Closed